Dana-Farber Cancer Institute
The Senior Scientist position at Dana-Farber Cancer Institute involves developing and implementing next-generation sequencing (NGS) workflows to advance the understanding of genome instability in HR-deficient cancers and translate findings into therapeutic applications. The role requires collaboration with academic and biopharma industry partners, contributing to manuscripts and grant applications, and presenting data at scientific meetings. The position also includes supervising technical assistants and mentoring lab members.
Headquarters
Boston, Massachusetts, United States
Company Size
1001-5000 employees
Founded
1947
Dana‑Farber Cancer Institute, based in Boston, MA, is a world‑leading cancer center specializing in adult and pediatric cancer treatment and research. Its physician‑scientists deliver multidisciplinary patient care and develop many of the most advanced therapies, including targeted treatments and clinical trials. Dana‑Farber combines cutting‑edge laboratory research with translational programs, prevention and survivorship services, and education to improve outcomes. Patients and clinicians turn to Dana‑Farber for its expertise, comprehensive care teams, and strong research pipeline.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Dana-Farber Cancer Institute.
DNA company aids Horry Co. in solving cold cases
Nov 26, 2025